Shattuck Labs, Inc. Customer Refund Liability, Current
Shattuck Labs, Inc. (STTK) had Customer Refund Liability, Current of $1.61 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:CustomerRefundLiabilityCurrent · last filed 2024-11-14
- 2024-09-30: Customer Refund Liability, Current $1.61M.
- 2023-12-31: Customer Refund Liability, Current $0.00.
| Period end | Customer Refund Liability, Current |
|---|---|
| 2024-09-30 | $1.61M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |